Valuation EUROAPI London S.E.

Stocks

Market Closed - London S.E. Other stock markets 01:30:00 04/08/26 am AEST			5-day change	1st Jan Change
0.9490 ^EUR	-2.01%		-22.72%	-58.06%

30/07	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026
30/07	Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,302	543.9	274.4	216.1	91.09	-	-
Change	-	-58.23%	-49.55%	-21.22%	-57.85%	-	-
Enterprise Value (EV) ¹	1,348	734.9	270.5	167.7	192.1	149.9	169.3
Change	-	-45.5%	-63.2%	-37.98%	14.55%	-21.98%	12.97%
P/E	-86.6x	-2.84x	-2.09x	-1.02x	-0.53x	-1.9x	-9.7x
PBR	1.17x	0.59x	0.28x	0.27x	0.15x	0.14x	0.14x
PEG	7.8x	-0x	0.1x	-0x	0x	0x	0.1x
Capitalization / Revenue	1.33x	0.54x	0.3x	0.25x	0.12x	0.12x	0.12x
EV / Revenue	1.38x	0.73x	0.3x	0.2x	0.25x	0.2x	0.22x
EV / EBITDA	11.2x	7.89x	5.37x	2.53x	4.37x	2.57x	2.51x
EV / EBIT	28.5x	44x	-10.2x	-2.26x	-2.32x	-14.5x	-44.7x
EV / FCF	-11x	-5.75x	18.2x	3.35x	-2.21x	-7.89x	-11.1x
FCF Yield	-9.09%	-17.4%	5.51%	29.8%	-45.2%	-12.7%	-8.98%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.16	-2.02	-1.38	-2.23	-1.8	-0.503	-0.0987
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	976.6	1,013	911.9	848.2	756.3	763.2	784.3
EBITDA ¹	120	93.1	50.4	66.2	43.95	58.33	67.41
EBIT ¹	47.3	16.7	-26.4	-74.3	-82.8	-10.35	-3.788
Net income ¹	-15	-189.7	-130.6	-211.2	-170.8	-47.98	-9.285
Net Debt ¹	46.3	191	-3.9	-48.4	101	58.81	78.25
Reference price ²	13.8500	5.7300	2.8800	2.2700	0.9570	0.9570	0.9570
Nbr of stocks (in thousands)	94,010	94,913	95,263	95,214	95,188	-	-
Announcement Date	8/3/23	28/2/24	3/3/25	3/3/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.36x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
NOVARTIS AG	22.21x	5.74x	14.32x	2.8%	297B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
Average	16.73x	6.45x	16.70x	2.43%	397.08B
Weighted average by Cap.	24.34x	7.70x	18.23x	2.01%